GoodRx

Sentry Acquires Codecov

Retrieved on: 
Wednesday, November 30, 2022
Software, Technology, Data Management, Apps, Applications, Lyft, Environment, Organization, Engineering, GoodRx, Acquisition, Language, Workflow, Friction, The Walt Disney Company, Rockstar Games, GitHub, Rock Star, Investment, Satellite navigation device, Online shopping, Risk management, Dribbble, Supercell, Eventbrite, Cloudflare, Sentry, The Washington Post

Sentry , the leader in developer-first application monitoring, today announced it has acquired Codecov , the leading dedicated code coverage reporting solution, providing developers with actionable insights into their workflow.

Key Points: 
  • Sentry , the leader in developer-first application monitoring, today announced it has acquired Codecov , the leading dedicated code coverage reporting solution, providing developers with actionable insights into their workflow.
  • Similar to Sentry, Codecov works within developers existing workflows for software development, providing feedback, insight, and ownership over the quality of code regardless of platform, language, or CI/CD tooling.
  • Theres an obvious alignment between Sentry and Codecov in how we empower developers to feel confident in making and shipping changes.
  • Read the Sentry and Codecov blogs to learn more about how the companies will work together to bring a new level of actionable insight directly into the developers workflow.

DocGo Appoints Veteran Technology Human Resources Executive Vina Leite, MS, to its Board of Directors and Announces Key Leadership Promotions

Retrieved on: 
Monday, November 14, 2022
Professional Services, Other Health, Health, General Health, Marketing, Communications, Health Technology, Other Professional Services, Human Resources, Telemedicine, Virtual Medicine, Finance, Society for Human Resource Management, The Trade Desk, Specialization, Uncertainty, TTD, Rhode Island College, Behavior, Treasurer, Roger Williams University, SHRM, Patient, UNICOM, Society, Human resources, Information technology, EVP, QLogic, Human, Culture, Capital market, MS, Security (finance), EMC, MHealth, JAMF, Organization, Business, GoodRx, Workplace, Capella University, Health, Management, Risk management, Science

DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services, today announced that it has appointed veteran human resources executive Vina Leite, MS, to its Board of Directors.

Key Points: 
  • DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services, today announced that it has appointed veteran human resources executive Vina Leite, MS, to its Board of Directors.
  • The company also announced key leadership promotions that will be effective December 31, 2022.
  • I look forward to leveraging my years of experience in human capital to create a culture that will advance the organizations success.
  • Prior to that, she served as COO/Vice President of Human Resources at EMC, an information technology provider, and, before, Chief Human Resources Officer at UNICOM.

Lasso's Endemic Marketplace Unlocks Elusive HCPs for BioPharm Communications

Retrieved on: 
Tuesday, November 15, 2022
HCP, BioPharm (US company), Degenerative disease, Physician, Industry, Health care, Prescription, Marketing, Patient, BMJ, Publication, HCPS, Associate, GoodRx, Lasso, Health insurance, Public relations

AUSTIN, Texas, Nov. 15, 2022 /PRNewswire/ -- Lasso (lassoplatform.io), an end-to-end operating system for healthcare marketing and analytics, today released the powerful results of an exciting HCP campaign with BioPharm Communications leveraging Lasso's Premium Endemic Publisher Marketplace for a leading brand of heart disease medication.

Key Points: 
  • AUSTIN, Texas, Nov. 15, 2022 /PRNewswire/ --Lasso (lassoplatform.io), an end-to-end operating system for healthcare marketing and analytics, today released the powerful results of an exciting HCP campaign with BioPharm Communications leveraging Lasso's Premium Endemic Publisher Marketplace for a leading brand of heart disease medication.
  • In May, Lasso launched their Publisher Suite and Endemic Marketplace to provide the ultimate end-to-end solution for the healthcare communications industry.
  • Leveraging Lasso's Endemic Marketplace, BioPharm achieved an incremental HCP reach of 1.76%, surpassing Lasso's average benchmark for endemic campaigns by almost 70%.
  • For nearly 20 years, BioPharm has leveraged a proprietary data-driven approach to omnichannel campaigns focused on the most valuable target HCPs for pharma and biotech brands.

Truepill Closes Fundraising Round to Refocus on Core Pharmacy and Accelerated Customer Growth

Retrieved on: 
Friday, November 11, 2022
Health, FDA, Pharmacy, Investment, URAC, Entrepreneurship, GLOBE, Solution, GoodRx, SAN, Accreditation, NABP, B2B, API, Growth, Renewable energy

The fundraising round is timed with Truepills strategy to focus on its core pharmacy business.

Key Points: 
  • The fundraising round is timed with Truepills strategy to focus on its core pharmacy business.
  • In his new role, Greenall will align customer retention and growth with expanded operational capabilities including the companys newest, high volume facility based in Cincinnati, Ohio.
  • Truepill powers the future of consumer healthcare by enabling our customers to deliver modern, digital-first pharmacy experiences at scale.
  • With a nationwide network of owned and operated pharmacies and fulfillment centers, Truepill accreditations include URAC accredited mail order pharmacy, URAC accredited specialty pharmacy, NABP, Digital Pharmacy Accreditation and FDA registration.

Wheel Acquires GoodRx Care Backend Technology to Strengthen its Virtual-First Care Platform

Retrieved on: 
Friday, November 11, 2022
Multimedia, Software, Industry, Annual report, Risk, Private Securities Litigation Reform Act, Technology, Solution, GoodRx, SVP, EMR, Acquisition, Patient, SEC, Online shopping, Pharmaceutical industry, Public relations, Wheel

AUSTIN, Texas, Nov. 11, 2022 /PRNewswire/ -- Wheel, the health technology company powering the future of care, today announced it will acquire GoodRx Care's backend virtual care technology, including its clinician-centric EMR, powerful clinical management tools, and flexible patient experience software. Wheel will integrate GoodRx Care's underlying technology to expand its existing virtual care platform capabilities and GoodRx will continue to own the consumer-facing GoodRx Care website and mobile app.

Key Points: 
  • Wheel will integrate GoodRx Care's underlying technology to expand its existing virtual care platform capabilities and GoodRx will continue to own the consumer-facing GoodRx Care website and mobile app.
  • Wheel will combine the best features of Wheel and GoodRx Care's technology in one platform, thereby empowering its customers to build and deliver innovative care services, and accelerate growth into new care models and markets mobilizing the digital transformation of care.
  • Since 2020, Wheel has provided its technology and trusted nationwide clinician network for the GoodRx Care service.
  • "Wheel has provided technology and clinicians for GoodRx Care for several years, giving us high confidence in their ability to operate and grow the platform.

New Report from GoodRx Shows Positive Impact of Giving Pharmacists the Power to Prescribe

Retrieved on: 
Thursday, November 3, 2022
Apps, Applications, Technology, Electronic Commerce, Health Technology, Software, Internet, AIDS, Health, Pharmaceutical, Private Securities Litigation Reform Act, Research, Digital, HCPS, Asthma, Occupational burnout, Pharmacy, HIV, NASDAQ, Acquisition, Pharmacist, Pre-exposure prophylaxis, Diabetes, Gaps, Technology, SEC, Patient, MPH, Pharmaceutical industry, Medicine, GoodRx

The average person sees their pharmacists nearly 12 times more frequently than their HCPs, creating an enormous opportunity to bridge current gaps in the healthcare system.

Key Points: 
  • The average person sees their pharmacists nearly 12 times more frequently than their HCPs, creating an enormous opportunity to bridge current gaps in the healthcare system.
  • According to previous research, only 25% of those eligible for PrEP actually receive it, despite its strong efficacy.
  • A few states currently allow pharmacists to prescribe other medications, including birth control, smoking cessation medications, and medications for conditions such as asthma and diabetes.
  • When access improves, as we saw with this study, so does adherence, said Tori Marsh, MPH, Director of Research at GoodRx.

GoodRx to Present at Upcoming Investor Conferences

Retrieved on: 
Thursday, October 27, 2022
Internet, Other Health, Health, Apps, Applications, Technology, GoodRx, Company, Conference, Digital, Nasdaq, The Information (company), Wells Fargo, CA, Credit Suisse, Investor relations, Technology, Credit, Video game

Following each conference, archived recordings will be available on the Companys website for at least 30 days.

Key Points: 
  • Following each conference, archived recordings will be available on the Companys website for at least 30 days.
  • GoodRx is a leading consumer-focused digital healthcare platform.
  • Our technology delivers strong savings, trusted information and access to care to make healthcare affordable and convenient for all Americans.
  • Since 2011, we have helped consumers save over $40 billion and are one of the most downloaded medical apps over the past decade.

Redi.Health Sees Tremendous Growth for Platform that Empowers Patients to Understand, Manage and Track their Health with Digital Support

Retrieved on: 
Monday, October 17, 2022
Adoption, Quality of life, Technology, Growth, MCP, Redi, Patient, Exercise, Industry, CEO, M25, Diet, GoodRx, LabCorp, Health insurance, Health

COLUMBUS, Ohio, Oct. 17, 2022 /PRNewswire-PRWeb/ -- Today, Redi.Health, provider of the leading health management technology that puts patient support in your pocket, is announcing it has secured growth capital led by Refinery Ventures, with participation from repeat investors MCP, Rev1 Ventures, and M25. The funding follows the company's recent seed financing round and helps support increased demand for the platform, which has seen continued adoption from patients across the nation.

Key Points: 
  • The funding follows the company's recent seed financing round and helps support increased demand for the platform, which has seen continued adoption from patients across the nation.
  • Redi.Health combines health management technology and pharmaceutical manufacturer support into one platform to enable patients to manage their complete health with a single interface.
  • Redi.Health empowers patients with chronic conditions to understand, manage and track their total health through digital support.
  • By delivering a pathway for pharmaceutical companies, providers, and patients to connect and engage, Redi.Health customizes the complete health journey to drive better health outcomes.

GoodRx and Biogen Collaborate to Help Enhance Enrollment Experience for Providers Who Have Chosen to Start Multiple Sclerosis Patients on VUMERITY®

Retrieved on: 
Thursday, October 13, 2022
Health, Telemedicine, Virtual Medicine, Health Technology, Health Insurance, Pharmaceutical, Biotechnology, News, U.S. Securities and Exchange Commission, Time, Risk, Health care, SEC, Nausea, MS, Science, Degenerative disease, Multiple sclerosis, Workflow, Angioedema, Infection, Nobel Prize, HCPS, NASDAQ, Liver injury, Neuroscience, Patient, Biotechnology, Diarrhea, Abdominal pain, Spinal muscular atrophy, Selected Patient Information Resources in Asian Languages, Multimedia, Technology, Private Securities Litigation Reform Act, Progressive multifocal leukoencephalopathy, Solution, Anaphylaxis, Prescription, Disability, Shingles, Acquisition, Health, Dimethyl fumarate, Climate, BIIB, HCP, Clinical trial, Excipient, Brain, Intellectual property, Hypersensitivity, Death, Failure, US Organization, COVID-19, Lists of diseases, Pathology, Flushing, View, Pharmaceutical industry, Risk management, Biogen, GoodRx

HCPs who have decided to start patients with relapsing forms of multiple sclerosis (MS) on VUMERITY (diroximel fumarate) may now find the enrollment form and submit to the specialty hub through Provider Mode .

Key Points: 
  • HCPs who have decided to start patients with relapsing forms of multiple sclerosis (MS) on VUMERITY (diroximel fumarate) may now find the enrollment form and submit to the specialty hub through Provider Mode .
  • Announced today, GoodRxs Provider Mode is a new experience built specifically for HCPs to help them access solutions for the medications they prescribe.
  • We are proud to work with medical professionals to help patients with relapsing MS get the therapy they need more efficiently.
  • This exciting integration with Biogen is just the start of the great work to come as we expand our offerings for providers.

GoodRx Announces Provider Mode, An Innovative Experience Built Specifically for Healthcare Providers

Retrieved on: 
Thursday, October 13, 2022
Software, Other Health, General Health, Mobile, Wireless, Networks, Internet, Pharmaceutical, Telemedicine, Virtual Medicine, Apps, Applications, Technology, Health Technology, Practice Management, Health, News, SEC, Growth, MS, Pharmacy, Multiple sclerosis, News Feed, Patient, Indian Medical Association, Michigan Education Savings Program, Biogen, Multimedia, Providers, Technology, Private Securities Litigation Reform Act, Digital, Acquisition, MD, Industry, Health, Face, NPS, American Medical Association, HCP, Pharmacist, Solution, HCPS, Pharmaceutical industry, Online shopping, Health insurance, GoodRx

GoodRx (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced the launch of Provider Mode , a new experience that is built specifically for healthcare providers (HCPs) to help them find affordable solutions for the medications they prescribe.

Key Points: 
  • GoodRx (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced the launch of Provider Mode , a new experience that is built specifically for healthcare providers (HCPs) to help them find affordable solutions for the medications they prescribe.
  • Built by GoodRxs own team of medical professionals along with external healthcare provider focus groups, Provider Mode offers customized tools designed to help HCPs and office staff support patients throughout their healthcare journey.
  • Our new Provider Mode experience makes finding patient savings faster and easier for healthcare professionals, which helps them achieve better patient outcomes.
  • GoodRx today announced a collaboration with Biogen that aims to improve the patient and healthcare provider (HCP) experience when initiating a new specialty therapy.